Angiolillo, A.
1244  Ergebnisse:
Personensuche X
?
3

Repeat coronary revascularization in high-risk patients tre..:

Spirito, A ; Baber, U ; Sartori, S...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
4

Factor XI inhibitors in early clinical trials: a meta-analy..:

Galli, M ; Laborante, R ; Ortega-Paz, L...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
5

Pharmacodynamic and pharmacokinetic profiles associated wit..:

Franchi, F ; Rollini, F ; Ortega Paz, L...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
6

Mortality with bivalirudin plus a high-dose infusion versus..:

Galli, M ; Gargiulo, G ; Benenati, S..
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
 
?
 
?
9

Direct stenting versus stenting after predilatation in STEM..:

Vogel, R F ; Delewi, R ; Wilschut, J M...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
 
?
10

Revascularization strategies versus optimal medical therapy..:

Galli, M ; Benenati, S ; Zito, A...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
 
?
12

Body mass index and efficacy and safety of ticagrelor versu..:

Lahu, S ; Behnes, M ; Ndrepepa, G...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
13

Guided and unguided de-escalation from potent P2Y12 inhibit..:

Tavenier, A H ; Chiarito, M ; Cao, D...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
14

Ticagrelor monotherapy after percutaneous coronary interven..:

Cao, D ; Baber, U ; Dangas, G...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
15

Efficacy and safety of dual pathway inhibition in patients ..:

Galli, M ; Capodanno, D ; D'Amario, D...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
1-15